https://www.indianpharmapost.com/tillotts-pharma-and-tvm-capital-form-mage-biologics-to-develop-oral-antibody-therapy-for-ulcerative-colitis-144082023-07-21T00:00:00+05:30always0.9https://www.indianpharmapost.com/kintor-pharma-completes-first-patient-enrollment-in-long-term-safety-phase-iii-trial-of-kx-826-144092023-07-21T00:00:00+05:30always0.9https://www.indianpharmapost.com/riparian-pharmaceuticals-inks-license-and-research-agreement-with-pfizer-for-cardiovascular-programs-144102023-07-21T00:00:00+05:30always0.9https://www.indianpharmapost.com/mercks-phase-3-keynote-a18-trial-met-pfs-in-patients-with-advanced-cervical-cancer-144112023-07-21T00:00:00+05:30always0.9